Sfoglia per Autore
Frequency and clinical correlates of JAK2 46/1 (GGCC) haplotype in primary myelofibrosis
2010-01-01 Guglielmelli, P.; Biamonte, F.; Spolverini, A.; Pieri, L.; Isgrò, A.; Antonioli, E.; Pancrazzi, A.; Bosi, A.; Barosi, G.; Vannucchi, A. M.
EZH2 mutational status predicts poor survival in myelofibrosis
2011-01-01 Guglielmelli, P; Biamonte, F; Score, J; Hidalgo-Curtis, C; Cervantes, F; Maffioli, M; Fanelli, T; Ernst, T; Winkelman, N; Jones, Av; Zoi, K; Reiter, A; Duncombe, A; Villani, L; Bosi, A; Barosi, G; Cross, Ncp; Vannucchi, Am
Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis
2011-01-01 Guglielmelli, Paola; Barosi, Giovanni; Rambaldi, Alessandro; Marchioli, Roberto; Masciulli, Arianna; Tozzi, Lorenzo; Biamonte, Flavia; Bartalucci, Niccolò; Gattoni, Elisabetta; Lupo Maria, Letizia; Finazzi, Guido; Pancrazzi, Alessandro; Antonioli, Elisabetta; Susini Maria, Chiara; Pieri, Lisa; Malevolti, Elisa; Usala, Emilio; Occhini, Ubaldo; Grossi, Alberto; Caglio, Silvia; Paratore, Simona; Bosi, Alberto; Barbui, Tiziano; Vannucchi Alessandro, M
Epigenetics and mutations in chronic myeloproliferative neoplasms
2011-01-01 Vannucchi, Am; Biamonte, F
Characterisation and discovery of novel miRNAs andmoRNAs in JAK2V617F mutated SET2 cells
2012-01-01 S., Bortoluzzi; A., Bisognin; M., Biasolo; Guglielmelli, Paola; Biamonte, Flavia; R., Norfo; R., Manfredini; Vannucchi, ALESSANDRO MARIA
The ERCC2 Gln/Gln polymorphism at codon 751 is not associated with leukaemic transformation in primary myelofibrosis
2013-01-01 Susini, Mc; Guglielmelli, P; Spolverini, A; Biamonte, F; Mannarelli, C; Barosi, G; Zoi, K; Reiter, A; Duncombe, A; Cervantes, F; Cazzola, M; Cross, N; Vannucchi, Am.
Mutations and prognosis in primary myelofibrosis
2013-01-01 Vannucchi, ALESSANDRO MARIA; Lasho, Tl; Guglielmelli, Paola; Biamonte, Flavia; Pardanani, A; Pereira, A; Finke, C; Score, J; Gangat, N; Mannarelli, Carmela; Ketterling, Rp; Rotunno, Giada; Knudson, Ra; Susini, Mc; Laborde, Rr; Spolverini, Ambra; Pancrazzi, Alessandro; Pieri, Lisa; Manfredini, R; Tagliafico, E; Zini, R; Jones, A; Zoi, K; Reiter, A; Duncombe, A; Pietra, D; Rumi, E; Cervantes, F; Barosi, G; Cazzola, M; Cross, Nc; Tefferi, A.
Mutational analysis of BCORL1 in the leukemic transformation of chronic myeloproliferative neoplasms
2014-01-01 Rotunno, G; Guglielmelli, P; Biamonte, F; Rumi, E; Cazzola, M; Vannucchi, Am
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms
2014-01-01 Tenedini, E; Bernardis, I; Artusi, V; Artuso, L; Roncaglia, E; Guglielmelli, P; Pieri, L; Bogani, C; Biamonte, F; Rotunno, G; Mannarelli, C; Bianchi, E; Pancrazzi, A; Fanelli, T; Malagoli Tagliazucchi, G; Ferrari, S; Manfredini, R; Vannucchi, Am; Tagliafico, E.
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients
2014-01-01 Guglielmelli, P; Lasho, Tl; Rotunno, G; Score, J; Mannarelli, C; Pancrazzi, A; Biamonte, F; Pardanani, A; Zoi, K; Reiter, A; Duncombe, A; Fanelli, T; Pietra, D; Rumi, E; Finke, C; Gangat, N; Ketterling, Rp; Knudson, Ra; Hanson, Ca; Bosi, A; Pereira, A; Manfredini, R; Cervantes, F; Barosi, G; Cazzola, M; Cross, Nc; Vannucchi, Am; Tefferi, A
Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study
2014-01-01 Guglielmelli, P; Biamonte, F; Rotunno, G; Artusi, V; Artuso, L; Bernardis, I; Tenedini, E; Pieri, L; Paoli, C; Mannarelli, C; Fjerza, ; R, ; Rumi, E; Stalbovskaya, V; Squires, M; Cazzola, M; Manfredini, R; Harrison, C; Tagliafico, E; Vannucchi, Am
H-ferritin-regulated MicroRNAs modulate gene expression in K562 cells
2015-01-01 Biamonte, F; Zolea, F; Bisognin, A; Di Sanzo, M; Saccoman, C; Scumaci, D; Aversa, I; Panebianco, M; Faniello, C; Bortoluzzi, S; Cuda, G; Costanzo, F
H ferritin silencing induces protein misfolding in K562 cells: A Raman analysis
2015-01-01 Zolea, Fabiana; Biamonte, Flavia; Candeloro, Patrizio; DI SANZO, Maddalena; Anna, Cozzi; DI VITO, Anna; Quaresima, Barbara; Lobello, Nadia; Trecroci, Francesca; DI FABRIZIO, Enzo Mario; Sonia, Levi; Cuda, Giovanni; Costanzo, F
Ferritin heavy chain is a negative regulator of ovarian cancer stem cell expansion and epithelial to mesenchymal transition.
2016-01-01 Lobello, N; Biamonte, F; Pisanu, Me; Faniello, C; Jakopin, Ž; Chiarella, E; Giovannone, Ed; Mancini, R; Cuda, G; Costanzo, F; Ciliberto, G
Caffeine Positively Modulates Ferritin Heavy Chain Expression in H460 Cells: Effects on Cell Proliferation.
2016-01-01 Zolea, F; Biamonte, F; Battaglia, Am; Faniello, C; Cuda, G; Costanzo, F
FTH1P3, a Novel H-Ferritin Pseudogene Transcriptionally Active, Is Ubiquitously Expressed and Regulated during Cell Differentiation.
2016-01-01 Di Sanzo, M; Aversa, I; Santamaria, G; Gagliardi, M; Panebianco, M; Biamonte, F; Zolea, F; Faniello, C; Cuda, G; Costanzo, F
Ferritin Heavy Subunit Silencing Blocks the Erythroid Commitment of K562 Cells via miR-150 up-Regulation and GATA-1 Repression
2017-01-01 Zolea, F; Battaglia, Am; Chiarella, E; Marco, C; Bond, H; Morrone, G; Biamonte, F; Malanga, D; Costanzo, F
Human haematological and epithelial tumor-derived cell lines express distinct patterns of onco-microRNAs.
2017-01-01 Biamonte, F; Zolea, F; Santamaria, G; Battaglia, Am; Costanzo, F; Cuda, G
Epithelial-to-mesenchymal transition in FHC-silenced cells: the role of CXCR4/CXCL12 axis
2017-01-01 Aversa, I; Zolea, F; Ieranò, C; Bulotta, S; Trotta, Am; Faniello, C; De Marco, C; Malanga, D; Biamonte, F; Viglietto, G; Cuda, G; Scala, S; Costanzo, F
Innovative experimental approach for the morphological characterization of cancer stem cells spheroids
2018-01-01 DI VITO, Anna; Mignogna, Chiara; Biamonte, Flavia; Barni, Tullio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Frequency and clinical correlates of JAK2 46/1 (GGCC) haplotype in primary myelofibrosis | 1-gen-2010 | Guglielmelli, P.; Biamonte, F.; Spolverini, A.; Pieri, L.; Isgrò, A.; Antonioli, E.; Pancrazzi, A.; Bosi, A.; Barosi, G.; Vannucchi, A. M. | |
| EZH2 mutational status predicts poor survival in myelofibrosis | 1-gen-2011 | Guglielmelli, P; Biamonte, F; Score, J; Hidalgo-Curtis, C; Cervantes, F; Maffioli, M; Fanelli, T; Ernst, T; Winkelman, N; Jones, Av; Zoi, K; Reiter, A; Duncombe, A; Villani, L; Bosi, A; Barosi, G; Cross, Ncp; Vannucchi, Am | |
| Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis | 1-gen-2011 | Guglielmelli, Paola; Barosi, Giovanni; Rambaldi, Alessandro; Marchioli, Roberto; Masciulli, Arianna; Tozzi, Lorenzo; Biamonte, Flavia; Bartalucci, Niccolò; Gattoni, Elisabetta; Lupo Maria, Letizia; Finazzi, Guido; Pancrazzi, Alessandro; Antonioli, Elisabetta; Susini Maria, Chiara; Pieri, Lisa; Malevolti, Elisa; Usala, Emilio; Occhini, Ubaldo; Grossi, Alberto; Caglio, Silvia; Paratore, Simona; Bosi, Alberto; Barbui, Tiziano; Vannucchi Alessandro, M | |
| Epigenetics and mutations in chronic myeloproliferative neoplasms | 1-gen-2011 | Vannucchi, Am; Biamonte, F | |
| Characterisation and discovery of novel miRNAs andmoRNAs in JAK2V617F mutated SET2 cells | 1-gen-2012 | S., Bortoluzzi; A., Bisognin; M., Biasolo; Guglielmelli, Paola; Biamonte, Flavia; R., Norfo; R., Manfredini; Vannucchi, ALESSANDRO MARIA | |
| The ERCC2 Gln/Gln polymorphism at codon 751 is not associated with leukaemic transformation in primary myelofibrosis | 1-gen-2013 | Susini, Mc; Guglielmelli, P; Spolverini, A; Biamonte, F; Mannarelli, C; Barosi, G; Zoi, K; Reiter, A; Duncombe, A; Cervantes, F; Cazzola, M; Cross, N; Vannucchi, Am. | |
| Mutations and prognosis in primary myelofibrosis | 1-gen-2013 | Vannucchi, ALESSANDRO MARIA; Lasho, Tl; Guglielmelli, Paola; Biamonte, Flavia; Pardanani, A; Pereira, A; Finke, C; Score, J; Gangat, N; Mannarelli, Carmela; Ketterling, Rp; Rotunno, Giada; Knudson, Ra; Susini, Mc; Laborde, Rr; Spolverini, Ambra; Pancrazzi, Alessandro; Pieri, Lisa; Manfredini, R; Tagliafico, E; Zini, R; Jones, A; Zoi, K; Reiter, A; Duncombe, A; Pietra, D; Rumi, E; Cervantes, F; Barosi, G; Cazzola, M; Cross, Nc; Tefferi, A. | |
| Mutational analysis of BCORL1 in the leukemic transformation of chronic myeloproliferative neoplasms | 1-gen-2014 | Rotunno, G; Guglielmelli, P; Biamonte, F; Rumi, E; Cazzola, M; Vannucchi, Am | |
| Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms | 1-gen-2014 | Tenedini, E; Bernardis, I; Artusi, V; Artuso, L; Roncaglia, E; Guglielmelli, P; Pieri, L; Bogani, C; Biamonte, F; Rotunno, G; Mannarelli, C; Bianchi, E; Pancrazzi, A; Fanelli, T; Malagoli Tagliazucchi, G; Ferrari, S; Manfredini, R; Vannucchi, Am; Tagliafico, E. | |
| The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients | 1-gen-2014 | Guglielmelli, P; Lasho, Tl; Rotunno, G; Score, J; Mannarelli, C; Pancrazzi, A; Biamonte, F; Pardanani, A; Zoi, K; Reiter, A; Duncombe, A; Fanelli, T; Pietra, D; Rumi, E; Finke, C; Gangat, N; Ketterling, Rp; Knudson, Ra; Hanson, Ca; Bosi, A; Pereira, A; Manfredini, R; Cervantes, F; Barosi, G; Cazzola, M; Cross, Nc; Vannucchi, Am; Tefferi, A | |
| Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study | 1-gen-2014 | Guglielmelli, P; Biamonte, F; Rotunno, G; Artusi, V; Artuso, L; Bernardis, I; Tenedini, E; Pieri, L; Paoli, C; Mannarelli, C; Fjerza, ; R, ; Rumi, E; Stalbovskaya, V; Squires, M; Cazzola, M; Manfredini, R; Harrison, C; Tagliafico, E; Vannucchi, Am | |
| H-ferritin-regulated MicroRNAs modulate gene expression in K562 cells | 1-gen-2015 | Biamonte, F; Zolea, F; Bisognin, A; Di Sanzo, M; Saccoman, C; Scumaci, D; Aversa, I; Panebianco, M; Faniello, C; Bortoluzzi, S; Cuda, G; Costanzo, F | |
| H ferritin silencing induces protein misfolding in K562 cells: A Raman analysis | 1-gen-2015 | Zolea, Fabiana; Biamonte, Flavia; Candeloro, Patrizio; DI SANZO, Maddalena; Anna, Cozzi; DI VITO, Anna; Quaresima, Barbara; Lobello, Nadia; Trecroci, Francesca; DI FABRIZIO, Enzo Mario; Sonia, Levi; Cuda, Giovanni; Costanzo, F | |
| Ferritin heavy chain is a negative regulator of ovarian cancer stem cell expansion and epithelial to mesenchymal transition. | 1-gen-2016 | Lobello, N; Biamonte, F; Pisanu, Me; Faniello, C; Jakopin, Ž; Chiarella, E; Giovannone, Ed; Mancini, R; Cuda, G; Costanzo, F; Ciliberto, G | |
| Caffeine Positively Modulates Ferritin Heavy Chain Expression in H460 Cells: Effects on Cell Proliferation. | 1-gen-2016 | Zolea, F; Biamonte, F; Battaglia, Am; Faniello, C; Cuda, G; Costanzo, F | |
| FTH1P3, a Novel H-Ferritin Pseudogene Transcriptionally Active, Is Ubiquitously Expressed and Regulated during Cell Differentiation. | 1-gen-2016 | Di Sanzo, M; Aversa, I; Santamaria, G; Gagliardi, M; Panebianco, M; Biamonte, F; Zolea, F; Faniello, C; Cuda, G; Costanzo, F | |
| Ferritin Heavy Subunit Silencing Blocks the Erythroid Commitment of K562 Cells via miR-150 up-Regulation and GATA-1 Repression | 1-gen-2017 | Zolea, F; Battaglia, Am; Chiarella, E; Marco, C; Bond, H; Morrone, G; Biamonte, F; Malanga, D; Costanzo, F | |
| Human haematological and epithelial tumor-derived cell lines express distinct patterns of onco-microRNAs. | 1-gen-2017 | Biamonte, F; Zolea, F; Santamaria, G; Battaglia, Am; Costanzo, F; Cuda, G | |
| Epithelial-to-mesenchymal transition in FHC-silenced cells: the role of CXCR4/CXCL12 axis | 1-gen-2017 | Aversa, I; Zolea, F; Ieranò, C; Bulotta, S; Trotta, Am; Faniello, C; De Marco, C; Malanga, D; Biamonte, F; Viglietto, G; Cuda, G; Scala, S; Costanzo, F | |
| Innovative experimental approach for the morphological characterization of cancer stem cells spheroids | 1-gen-2018 | DI VITO, Anna; Mignogna, Chiara; Biamonte, Flavia; Barni, Tullio |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile